Erica Szymanek
Adult Health · Shrewsbury, NJNPI 1568949691
Payments from drug & device makers
Across 366 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$896
- AstraZeneca$719
- Amgen$427
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$323
- Novo Nordisk$280
- Bayer$230
- plus $3K from 43 others
What the payments were for
- Food & beverage$5,503100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$125
- Reltone 200 Mg$117
- GLYCATE$117
- Reltone 400 Mg$117
- LINZESS$100
How this compares
$5,503 in reported general payments places this provider in the 90th percentile of 1,135 adult health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 77 | $78,957 |
| MounjaroTirzepatide | 46 | $46,833 |
| TrulicityDulaglutide | 31 | $36,929 |
| JanuviaSitagliptin Phosphate | 30 | $28,637 |
| FarxigaDapagliflozin Propanediol | 29 | $26,712 |
| Nurtec OdtRimegepant Sulfate | 12 | $23,959 |
| LinzessLinaclotide | 30 | $23,252 |
| EliquisApixaban | 32 | $22,943 |
| Xigduo XrDapaglifloz Propaned/Metformin | 22 | $19,181 |
| KerendiaFinerenone | 15 | $18,452 |
| JardianceEmpagliflozin | 13 | $16,388 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $12,330 |
| VascepaIcosapent Ethyl | 25 | $11,411 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $9,451 |
| Diclofenac Sodium | 91 | $5,936 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $167 | $83,76377 claims |
| Novo NordiskOzempic | $280 | $78,95777 claims |
| PfizerNurtec Odt, Eliquis | $100 | $46,90244 claims |
| MerckJanuvia, Janumet | $111 | $38,08846 claims |
| AstraZenecaFarxiga | $719 | $26,71229 claims |
| AbbVieLinzess | $896 | $23,25230 claims |
| BayerKerendia | $230 | $18,45215 claims |
| Boehringer IngelheimJardiance | $31 | $16,38813 claims |
| GSKTrelegy Ellipta | $220 | $12,33015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,135 adult health providers in New Jersey.
Other adult health in Shrewsbury
- June HalperHackensack$458K
- Kara SaggiomoCamden$127K
- Entela AhmetiPomona$75K
- Phyllis McKiernanHackensack$72K
- Denise ForceMiddletown$71K
- Kathleen SenecaHillsborough$64K
- Diane AndresenNorthvale$60K
- Dana BeenstockFreehold$51K
- Phyllis DudaCamden$46K
- Anthony WalkoWestwood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.